There are currently 831 clinical trials in Washington, District Of Columbia looking for participants to engage in research studies. Trials are conducted at various facilities, including Children's National Medical Center, MedStar Georgetown University Hospital, MedStar Washington Hospital Center and Walter Reed Army Medical Center. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Evaluation of The Food Allergy Mastery Program
NCT06034678
Recruiting
The proposed research project will evaluate a novel behavioral intervention that promotes early adolescent food allergy self-management and adjustment through 1) food allergy education, 2) problem-solving, communication, assertiveness, and anxiety management skill building, and 3) peer support.
Gender:
All
Ages:
Between 10 years and 14 years
Trial Updated:
09/05/2023
Locations: Childrens' National Hospital, Washington, District of Columbia
Conditions: Food Allergy in Children
Register for Updates
Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis
NCT05177107
Recruiting
This is a phase IIa randomized trial designed to evaluate bacteriophage therapy in patients with diabetic foot osteomyelitis.
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
09/05/2023
Locations: MedStar Washington Hospital Center, Washington, District of Columbia
Conditions: Osteomyelitis, Diabetic Foot Osteomyelitis
Register for Updates
Nerivio Device for Treatment of New Daily Headache Persistence (NDHP)
NCT05310227
Recruiting
The goal of this study is to examine the effects of the Remote Electrical Neuromodulation (REN) device on adolescents ages 12-17 who have been diagnosed with New Daily Persistent Headache (NDPH). Pediatric patients with a diagnosis of new daily persistent headache are typically resistant to standard pharmacologic treatments and often experience systemic side effects related to medications; thus, REN offers the potential for an exciting new treatment option for patients with refractory headache d... Read More
Gender:
All
Ages:
Between 12 years and 17 years
Trial Updated:
08/31/2023
Locations: Children's National Medical Center, Washington, District of Columbia
Conditions: New Daily Persistent Headache (NDPH)
Register for Updates
Group Visits for High Risk Type 1 Diabetes (T1D)
NCT05431686
Recruiting
The investigators propose to conduct a pilot prospective cohort study to assess the impact of shared medical appointments (SMA) visits in underserved youth with poorly controlled type 1 diabetes (T1D). The trial will employ an enrollment visit, SMA visits every 3 months over a 12 month study period, followed by a 6-month observational period to assess feasibility and acceptability of SMA and the impact on glycemic control, self-management skills, and health related quality of life.
Gender:
All
Ages:
8 years and above
Trial Updated:
08/31/2023
Locations: Children's National Hospital, Washington, District of Columbia
Conditions: Type 1 Diabetes
Register for Updates
AltaValve Early Feasibility Study Protocol
NCT03997305
Recruiting
Prospective, single-arm, multicenter study to evaluate the safety and performance of the AltaValve for the treatment of moderate to severe or severe mitral valve regurgitation in subjects who are considered high risk for mortality and morbidity from conventional open-heart surgery.
Gender:
All
Ages:
18 years and above
Trial Updated:
08/31/2023
Locations: MedStar Washington Hospital, Washington, District of Columbia
Conditions: Mitral Regurgitation, Mitral Insufficiency, Mitral Valve Incompetence, Mitral Valve Regurgitation, Mitral Incompetence
Register for Updates
Transform CV Risk in Diabetes
NCT05948969
Recruiting
This initiative supports a real-world study of practice and physician prescribing patterns and a quality improvement initiative evaluating best practices (including clinical decision support, facilitated referral to cardiometabolic team-based care model, and general educational tools/resources) to im-prove use of guideline-directed therapeutics known to lower cardiovascular risk (CV) in patients with type 2 diabetes (T2D).
Gender:
All
Ages:
18 years and above
Trial Updated:
07/13/2023
Locations: Multiple sites nationwide, Washington, District of Columbia
Conditions: Type 2 Diabetes
Register for Updates
Diabetic Foot Ulcers-Comparing Transforming Powder to Standard of Care
NCT05046158
Recruiting
Phase IV, randomized, prospective, multi-center, open-label, comparison of transforming powder dressing to standard of care dressing for healing diabetic foot ulcers.
Gender:
All
Ages:
Between 18 years and 89 years
Trial Updated:
06/27/2023
Locations: MedStar Georgetown University Hospital, Washington, District of Columbia +1 locations
Conditions: Diabetic Foot Ulcer
Register for Updates
Transcatheter Aortic Prosthesis Function: A Long-term Follow-up Study
NCT03002272
Recruiting
In this observational study, the investigators will enroll subjects who underwent TAVR or SAVR more than 3 years ago. Clinical and procedural data from the implant/surgery will be collected, alongside clinical and echocardiographic data from subsequent follow-up visits.
Gender:
All
Ages:
18 years and above
Trial Updated:
05/25/2023
Locations: Washington Hospital Center, Washington, District of Columbia
Conditions: Aortic Valve Replacement
Register for Updates
Impact of Nilotinib on Safety, Tolerability, Pharmacokinetics and Biomarkers in Dementia With Lewy Bodies
NCT04002674
Recruiting
Dementia with Lewy Bodies (DLB) is an alphasynucleinopathy and the second most common form of dementia in the elderly. DLB shares striking neuropathological and clinical similarities with both Parkinson's disease (PD) and Alzheimer's disease (AD). Nilotinib (Tasigna®, AMN107, Novartis, Switzerland) is approved by the FDA and is well tolerated for CML treatment at oral doses of 600-800mg daily. The Investigators propose to perform a phase II randomized, double blinded, placebo controlled study to... Read More
Gender:
All
Ages:
Between 25 years and 90 years
Trial Updated:
05/11/2023
Locations: MedStar Georgetown University Hospital, Washington, District of Columbia
Conditions: Dementia With Lewy Bodies
Register for Updates
Helping Toddlers and Parents Together
NCT04864808
Recruiting
Using stakeholder feedback (i.e., behavioral health providers & caregivers), the goal of this study is to develop a behavioral parenting program that focuses on both parent mental health and parenting for parents of toddlers (12-35 months old). Using a deployment focused intervention model, this study will : (1) develop an early parenting intervention for parents of at-risk toddlers which integrates a focus on parent mental health with evidence-based behavioral parenting strategies, and (2) exam... Read More
Gender:
All
Ages:
Between 12 months and 55 years
Trial Updated:
05/09/2023
Locations: Children's National Medical Center, Washington, District of Columbia
Conditions: ADHD, Parenting
Register for Updates
Vibroacoustic Study of Lung Development in Newborn Infants
NCT05827250
Recruiting
Investigators hypothesize that premature newborns with poor cardiopulmonary performance have higher morbidities and poorer physical and cognitive developmental outcomes. Investigators further hypothesize that audible sounds combined with novel inaudible vibrations above and below human perception interpreted with transparent and auditable AI algorithms can detect and identify early gas and fluid movement anomalies not uncovered by conventional tools in an non-invasive, easy, fast, and low cost... Read More
Gender:
All
Ages:
Between 0 years and 2 years
Trial Updated:
04/11/2023
Locations: Medstar Georgetown University Hospital, Washington, District of Columbia
Conditions: Prematurity, Premature Birth, Premature Lungs, Prematurity; Extreme
Register for Updates
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
NCT02205762
Recruiting
The LCH-IV is an international, multicenter, prospective clinical study for pediatric Langerhans Cell Histiocytosis LCH (age \< 18 years).
Gender:
ALL
Ages:
18 years and below
Trial Updated:
03/21/2023
Locations: Children's National Medical Center, Washington, District of Columbia
Conditions: Langerhans Cell Histiocytosis
Register for Updates